Sysmex has a global network of operations throughout the world. This section introduces our company profile and provides the locations of our offices and subsidiaries.
Sony Biotechnology will continue to develop, manufacture, sell, market, service and distribute high-quality, cell analysis, research instruments and reagents, including the recently announced Sony-branded SH800 cell sorter instrument.
The name change not only reflects a global integration of company operations, but also represents the maturing flow cytometry business which is developing innovative products and techniques that will improve the way researchers and scientists (...)
PRIMADIAG est une société française innovante développant des plateformes robotiques simples et puissantes pour l’automatisation rapide d’une grande variété de protocoles dans le domaine de la biologie et plus particulièrement en biologie moléculaire.
Perkin Elmer is a global leader focused on improving the health and safety of people and the environment.
NanoTemper Technologies develop highly innovative instrument and software solutions for biolomecular analytics.
Miltenyi Biotec develop and manufacture a portfolio of outstanding products ranging from unique cell labeling reagents, through sophisticated cell separation and analysis devices, to innovative systems for clinical applications.
Mauna Kea Technologies is a global medical device company leading innovation in endomicroscopy. The company’s flagship product, Cellvizio®, a probe-based Confocal Laser Endomicroscopy (pCLE) system, is used worldwide by physicians and researchers to image tissue at cellular resolution in vivo. For preclinical research, Cellvizio® Dual Band bridges the gap between existing conventional imaging modalities. By simple and direct contact with the tissue of interest, it allows the localization of a (...)
As a worldwide leader supplying the pharmaceutical and biotechnology industries with biopharmaceuticals, Lonza furnishes different markets with state-of-the-art products, services, and research.
As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response.
Covaris provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations, and manage compounds in the drug discovery process.